Moderna (MRNA) Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. LFTO
2. CMCSA
3. QNT
4. NVDA
5. VRDN
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to Moderna (MRNA) Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries

Moderna Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries

October 29, 2021 10:15 AM EDT

Q2 deliveries almost double a further 56.5 million in options exercised by COVAX, for a total 116.5 million doses for delivery in the second quarter of 2022

Per the original APA, COVAX Facility retains options for up to 233 million additional doses in 2022

Doses provided at lowest tiered price, in keeping with Modernas global access principles commitment

CAMBRIDGE, Mass.--(BUSINESS... More